83 FR 5808 - Bulk Manufacturer of Controlled Substances Application: Noramco, Inc.
DEPARTMENT OF JUSTICE
Drug Enforcement Administration Federal Register Volume 83, Issue 28 (February 9, 2018)
Drug Enforcement Administration
Federal Register Volume 83, Issue 28 (February 9, 2018)
| Page Range | 5808-5808 | |
| FR Document | 2018-02645 |
[Federal Register Volume 83, Number 28 (Friday, February 9, 2018)] [Notices] [Page 5808] From the Federal Register Online [www.thefederalregister.org] [FR Doc No: 2018-02645] ======================================================================= ----------------------------------------------------------------------- DEPARTMENT OF JUSTICE Drug Enforcement Administration [Docket No. DEA-392] Bulk Manufacturer of Controlled Substances Application: Noramco, Inc. ACTION: Notice of application. ----------------------------------------------------------------------- DATES: Registered bulk manufacturers of the affected basic classes, and applicants therefore, may file written comments on or objections to the issuance of the proposed registration on or before April 10, 2018. ADDRESSES: Written comments should be sent to: Drug Enforcement Administration, Attention: DEA Federal Register Representative/DRW, 8701 Morrissette Drive, Springfield, Virginia 22152. SUPPLEMENTARY INFORMATION: The Attorney General has delegated his authority under the Controlled Substances Act to the Administrator of the Drug Enforcement Administration (DEA), 28 CFR 0.100(b). Authority to exercise all necessary functions with respect to the promulgation and implementation of 21 CFR part 1301, incident to the registration of manufacturers, distributors, dispensers, importers, and exporters of controlled substances (other than final orders in connection with suspension, denial, or revocation of registration) has been redelegated to the Assistant Administrator of the DEA Diversion Control Division (``Assistant Administrator'') pursuant to section 7 of 28 CFR part 0, appendix to subpart R. In accordance with 21 CFR 1301.33(a), this is notice that on July 6, 2017, Noramco, Inc., 1440 Olympic Drive, Athens, Georgia 30601 applied to be registered as a bulk manufacturer for the basic classes of controlled substances: ------------------------------------------------------------------------ Drug Controlled substance code Schedule ------------------------------------------------------------------------ Cathinone.............................. 1235 I Gamma Hydroxybutyric Acid.............. 2010 I Marihuana Extract...................... 7350 I Marihuana.............................. 7360 I Tetrahydrocannabinols.................. 7370 I Codeine-N-oxide........................ 9053 I Dihydromorphine........................ 9145 I Hydromorphinol......................... 9301 I Morphine-N-oxide....................... 9307 I Amphetamine............................ 1100 II Lisdexamfetamine....................... 1205 II Methylphenidate........................ 1724 II Nabilone............................... 7379 II Codeine................................ 9050 II Dihydrocodeine......................... 9120 II Oxycodone.............................. 9143 II Hydromorphone.......................... 9150 II Hydrocodone............................ 9193 II Morphine............................... 9300 II Oripavine.............................. 9330 II Thebaine............................... 9333 II Opium tincture......................... 9630 II Oxymorphone............................ 9652 II Noroxymorphone......................... 9668 II Alfentanil............................. 9737 II Sufentanil............................. 9740 II Carfentanil............................ 9743 II Tapentadol............................. 9780 II Fentanyl............................... 9801 II ------------------------------------------------------------------------ The company plans to manufacture bulk active pharmaceutical ingredients (APIs) and reference standards for distribution to their customers. In reference to drug codes 7360 (marihuana) and 7370 (tetrahydrocannabinols), the company plans to bulk manufacture these drugs as synthetic. No other activities for these drug codes are authorized for this registration. Dated: January 31, 2018. Susan A. Gibson, Deputy Assistant Administrator. [FR Doc. 2018-02645 Filed 2-8-18; 8:45 am] BILLING CODE 4410-09-P
![5808 Federal Register / Vol. 83, No. 28 / Friday, February 9, 2018 / Notices
inspection at the Office of the Secretary Drug Administration, Attention: DEA Federal
Controlled substance Schedule
and on EDIS.3 code Register Representative/DRW, 8701
This action is taken under the Morrissette Drive, Springfield, Virginia
authority of section 337 of the Tariff Act Cathinone ..................... 1235 I
22152.
of 1930, as amended (19 U.S.C. 1337), Gamma Hydroxybutyric 2010 I
and of §§ 201.10 and 210.8(c) of the Acid. SUPPLEMENTARY INFORMATION: The
Marihuana Extract ........ 7350 I
Commission’s Rules of Practice and Attorney General has delegated his
Marihuana ..................... 7360 I
Procedure (19 CFR 201.10, 210.8(c)). Tetrahydrocannabinols 7370 I authority under the Controlled
By order of the Commission. Codeine-N-oxide ........... 9053 I Substances Act to the Administrator of
Issued: February 6, 2018. Dihydromorphine .......... 9145 I the Drug Enforcement Administration
Lisa R. Barton, Hydromorphinol ............ 9301 I (DEA), 28 CFR 0.100(b). Authority to
Morphine-N-oxide ......... 9307 I exercise all necessary functions with
Secretary to the Commission. Amphetamine ............... 1100 II
[FR Doc. 2018–02616 Filed 2–8–18; 8:45 am]
respect to the promulgation and
Lisdexamfetamine ........ 1205 II
BILLING CODE 7020–02–P Methylphenidate ........... 1724 II implementation of 21 CFR part 1301,
Nabilone ....................... 7379 II incident to the registration of
Codeine ........................ 9050 II manufacturers, distributors, dispensers,
DEPARTMENT OF JUSTICE Dihydrocodeine ............. 9120 II importers, and exporters of controlled
Oxycodone ................... 9143 II substances (other than final orders in
Drug Enforcement Administration Hydromorphone ............ 9150 II connection with suspension, denial, or
Hydrocodone ................ 9193 II
revocation of registration) has been
[Docket No. DEA–392] Morphine ....................... 9300 II
Oripavine ...................... 9330 II redelegated to the Assistant
Bulk Manufacturer of Controlled Thebaine ....................... 9333 II Administrator of the DEA Diversion
Substances Application: Noramco, Inc. Opium tincture .............. 9630 II Control Division (‘‘Assistant
Oxymorphone ............... 9652 II Administrator’’) pursuant to section 7 of
ACTION: Notice of application. Noroxymorphone .......... 9668 II 28 CFR part 0, appendix to subpart R.
Alfentanil ....................... 9737 II
DATES: Registered bulk manufacturers of Sufentanil ...................... 9740 II In accordance with 21 CFR
the affected basic classes, and Carfentanil .................... 9743 II 1301.33(a), this is notice that on
applicants therefore, may file written Tapentadol .................... 9780 II December 6, 2017, AMRI Rensselaer,
comments on or objections to the Fentanyl ........................ 9801 II Inc., 33 Riverside Avenue, Rensselaer,
issuance of the proposed registration on New York 12144 applied to be
or before April 10, 2018. The company plans to manufacture registered as a bulk manufacturer of the
bulk active pharmaceutical ingredients following basic classes of controlled
ADDRESSES: Written comments should
(APIs) and reference standards for substances:
be sent to: Drug Enforcement
distribution to their customers.
Administration, Attention: DEA Federal
In reference to drug codes 7360 Drug
Register Representative/DRW, 8701 Controlled substance Schedule
(marihuana) and 7370 code
Morrissette Drive, Springfield, Virginia
(tetrahydrocannabinols), the company
22152. Marihuana ..................... 7360 I
plans to bulk manufacture these drugs
SUPPLEMENTARY INFORMATION: The as synthetic. No other activities for these Tetrahydrocannabinols 7370 I
Attorney General has delegated his drug codes are authorized for this Amphetamine ............... 1100 II
authority under the Controlled registration. Lisdexamfetamine ........ 1205 II
Substances Act to the Administrator of Pentobarbital ................ 2270 II
Dated: January 31, 2018.
the Drug Enforcement Administration 4-Anilino-N-phenethyl-4- 8333 II
Susan A. Gibson, piperidine (ANPP).
(DEA), 28 CFR 0.100(b). Authority to
exercise all necessary functions with Deputy Assistant Administrator. Codeine ........................ 9050 II
respect to the promulgation and [FR Doc. 2018–02645 Filed 2–8–18; 8:45 am] Oxycodone ................... 9143 II
implementation of 21 CFR part 1301, BILLING CODE 4410–09–P Hydromorphone ............ 9150 II
incident to the registration of Hydrocodone ................ 9193 II
manufacturers, distributors, dispensers, Meperidine .................... 9230 II
importers, and exporters of controlled DEPARTMENT OF JUSTICE Morphine ....................... 9300 II
substances (other than final orders in
Drug Enforcement Administration
connection with suspension, denial, or The company plans to manufacture
revocation of registration) has been [Docket No. DEA–392] bulk controlled substances for use in
redelegated to the Assistant product development and for
Administrator of the DEA Diversion Bulk Manufacturer of Controlled distribution to its customers.
Control Division (‘‘Assistant Substances Application: AMRI
Rensselaer, Inc. In reference to drug codes 7360
Administrator’’) pursuant to section 7 of
(marihuana) and 7370 (THC), the
28 CFR part 0, appendix to subpart R.
In accordance with 21 CFR ACTION: Notice of application. company plans to bulk manufacture
1301.33(a), this is notice that on July 6, these drugs as synthetics. No other
DATES: Registered bulk manufacturers of activities for these drug codes are
sradovich on DSK3GMQ082PROD with NOTICES
2017, Noramco, Inc., 1440 Olympic
the affected basic classes, and authorized for this registration.
Drive, Athens, Georgia 30601 applied to
applicants therefore, may file written
be registered as a bulk manufacturer for Dated: January 31, 2018.
comments on or objections to the
the basic classes of controlled Susan A. Gibson,
issuance of the proposed registration on
substances: Deputy Assistant Administrator.
or before April 10, 2018.
3 Electronic Document Information System ADDRESSES: Written comments should [FR Doc. 2018–02644 Filed 2–8–18; 8:45 am]
(EDIS): https://edis.usitc.gov. be sent to: Drug Enforcement BILLING CODE 4410–09–P
VerDate Sep<11>2014 16:57 Feb 08, 2018 Jkt 244001 PO 00000 Frm 00055 Fmt 4703 Sfmt 9990 E:\FR\FM\09FEN1.SGM 09FEN1](https://thefederalregister.org/doc/83_FR_5836/page/1.svg)
Document Created: 2018-02-09 00:12:03
Document Modified: 2018-02-09 00:12:03
| Category | Regulatory Information | |
| Collection | Federal Register | |
| sudoc Class | AE 2.7: GS 4.107: AE 2.106: | |
| Publisher | Office of the Federal Register, National Archives and Records Administration | |
| Section | Notices | |
| Action | Notice of application. | |
| Dates | Registered bulk manufacturers of the affected basic classes, and applicants therefore, may file written comments on or objections to the issuance of the proposed registration on or before April 10, 2018. | |
| FR Citation | 83 FR 5808 |
2024 Federal Register | Disclaimer | Privacy Policy
USC | CFR | eCFR